These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2659241)

  • 1. Standardization of antimicrobial susceptibility testing.
    Barry AL
    Clin Lab Med; 1989 Jun; 9(2):203-19. PubMed ID: 2659241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should we reevaluate antibiotic breakpoints?
    Ferraro MJ
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S227-9. PubMed ID: 11524723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of anaerobe susceptibility testing in the United States.
    Hecht DW
    Clin Infect Dis; 2002 Sep; 35(Suppl 1):S28-35. PubMed ID: 12173105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparisons of the in vitro susceptibility testing results for garenoxacin using six different national methods: report from the garenoxacin international bridging study.
    Jones RN; Gordon KA; Biedenbach DJ
    J Antimicrob Chemother; 2004 Feb; 53(2):258-65. PubMed ID: 14729758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility testing of Mycobacterium tuberculosis (EUCAST document E.DEF 8.1)--report of the Subcommittee on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis of the European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).
    Drobniewski F; Rüsch-Gerdes S; Hoffner S;
    Clin Microbiol Infect; 2007 Dec; 13(12):1144-56. PubMed ID: 17727670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multidrug-resistant tuberculosis. 1. Drug susceptibility testing and its standardization].
    Abe C
    Kekkaku; 1998 Nov; 73(11):649-55. PubMed ID: 9866927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systems approach to improving antimicrobial susceptibility testing in clinical laboratories in the United States.
    Counts JM; Astles JR; Tenover FC; Hindler J
    J Clin Microbiol; 2007 Jul; 45(7):2230-4. PubMed ID: 17522281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quality control on antimicrobial susceptibility testings].
    Aihara M
    Rinsho Byori; 2000 Jan; Suppl 111():142-9. PubMed ID: 10804804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic susceptibility testing accuracy. Review of the College of American Pathologists Microbiology Survey, 1972-1983.
    Jones RN; Edson DC
    Arch Pathol Lab Med; 1985 Jul; 109(7):595-601. PubMed ID: 3839359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of susceptibility testing practices for Streptococcus pneumoniae--United States, February 2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 May; 51(18):392-4. PubMed ID: 12018795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility breakpoints: PK-PD and susceptibility breakpoints.
    Ambrose PG
    Treat Respir Med; 2005; 4 Suppl 1():5-11. PubMed ID: 15846151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Selection of appropriate antimicrobial agents to test and report by clinical microbiology laboratories].
    Koibuchi H; Shibuya Y; Kubo N; Kawano M; Itoh K
    Rinsho Byori; 2002 Oct; 50(10):992-9. PubMed ID: 12451681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on clinical antifungal susceptibility testing for Candida species.
    Lewis RE; Klepser ME; Pfaller MA
    Pharmacotherapy; 1998; 18(3):509-15. PubMed ID: 9620102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).
    Cuenca-Estrella M; Arendrup MC; Chryssanthou E; Dannaoui E; Lass-Florl C; Sandven P; Velegraki A; Rodriguez-Tudela JL;
    Clin Microbiol Infect; 2007 Oct; 13(10):1018-22. PubMed ID: 17697001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparability of laboratory diagnosis and antimicrobial susceptibility testing of Neisseria gonorrhoeae from reference laboratories in Western Europe.
    Ison CA; Martin IM; Lowndes CM; Fenton KA;
    J Antimicrob Chemother; 2006 Sep; 58(3):580-6. PubMed ID: 16807252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quality control for antimicrobial susceptibility test using correlation between MIC results].
    Ueno T; Hiramatsu K; Nakano T; Koga S; Magari Y; Saikawa T; Nasu M
    Rinsho Byori; 2002 Jul; 50(7):706-11. PubMed ID: 12187710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility testing practices for Streptococcus pneumoniae: results of a proficiency testing survey of clinical laboratories.
    Edson DC; Glick T; Massey LD
    Diagn Microbiol Infect Dis; 2006 Jul; 55(3):225-30. PubMed ID: 16545934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic kits in parasitology: which controls?].
    Rossi P
    Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data?
    Ernst EJ; Diekema DJ; BootsMiller BJ; Vaughn T; Yankey JW; Flach SD; Ward MM; Franciscus CL; Acosta E; Pfaller MA; Doebbeling BN
    Diagn Microbiol Infect Dis; 2004 Jun; 49(2):141-5. PubMed ID: 15183864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.